Experiments were designed to compare the relaxant activity of the new
nitrate ester ITF 296 in isolated arteries and veins of the dog and to
determine the extent of modulation by the endothelium of the response
to the compound. Rings (with and without endothelium) of coronary, ba
silar, mesenteric, and femoral arteries and of mesenteric, femoral, an
d saphenous veins were suspended in organ chambers for measurement of
changes in isometric tension. In all blood vessels without endothelium
, ITF 296 caused concentration-dependent relaxation. The order of pote
ncy (from measurements of ED(50)) was: basilar artery greater than or
equal to coronary artery > femoral artery > mesenteric vein > femoral
vein > saphenous vein > mesenteric artery. The maximal relaxation to I
TF 296 was greater in the arteries (with the exception of the mesenter
ic) than in veins. In all blood vessels except for the basilar artery,
nitroglycerin caused larger relaxations than ITF 296: The ED(50) for
nitroglycerin was comparable in all blood vessels studied except for t
he mesenteric artery, where it was less. ITF 296 did not cause hyperpo
larization of vascular smooth muscle in coronary arteries either with
or without endothelium. The presence of endothelial cells blunted the
relaxation to ITF 296 in basilar and coronary arteries, but not in the
other blood vessels studied. These results demonstrate that ITF 296 h
as a direct inhibitory effect on vascular smooth muscle, which is most
pronounced in coronary and cerebral arteries. These findings are in l
ine with the vascular selectivity profile reported for the compound in
vivo.